Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk

Abstract Numerous observational studies have highlighted associations between mitochondrial dysfunction and schizophrenia (SCZ), yet the causal relationship remains elusive. This study aims to elucidate the causal link between mitochondria-associated proteins and SCZ. We used summary data from a gen...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenxi Sun, Ping Sun, Jin Li, Qun Yang, Qing Tian, Shiting Yuan, Xueying Zhang, Peng Chen, Chuanwei Li, Xiaobin Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Schizophrenia
Online Access:https://doi.org/10.1038/s41537-025-00559-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585629762846720
author Wenxi Sun
Ping Sun
Jin Li
Qun Yang
Qing Tian
Shiting Yuan
Xueying Zhang
Peng Chen
Chuanwei Li
Xiaobin Zhang
author_facet Wenxi Sun
Ping Sun
Jin Li
Qun Yang
Qing Tian
Shiting Yuan
Xueying Zhang
Peng Chen
Chuanwei Li
Xiaobin Zhang
author_sort Wenxi Sun
collection DOAJ
description Abstract Numerous observational studies have highlighted associations between mitochondrial dysfunction and schizophrenia (SCZ), yet the causal relationship remains elusive. This study aims to elucidate the causal link between mitochondria-associated proteins and SCZ. We used summary data from a genome-wide association study (GWAS) of 66 mitochondria-associated proteins in 3,301 individuals from Europe, as well as a GWAS on the large, multi-ethnic ancestry of SCZ, involving 76,755 cases and 243,649 controls. We conducted bidirectional two-sample Mendelian randomization (MR) analyses, with inverse variance weighting (IVW) as the primary method. To account for multi-directionality and ensure robustness, we included MR-Egger, weighted median (WM), weighted mode, and simple mode methods as supplementary sensitivity analyses. Moreover, we explored the GWAS catalog and the Drug-Gene Interaction Database (DGIdb) to identify and evaluate potential therapeutic targets. MR analysis revealed significant genetically determined causal associations between ETHE1 (OR: 1.06), SOD (OR: 0.97), CALU3 (OR: 1.03), and C1QBP (OR: 1.05) and SCZ. According to the reverse MR analysis, a causal relationship was shown between SCZ and CA5A (OR: 1.09), DLD (OR: 1. 08), AIF1 (OR: 0.93), SerRS (OR: 0.93) and MULA of NFKB1 (OR: 0.77). After conducting the gene-drug analysis, HRG, F12, GPLD1, C1R, BCHE, CFH, PON1, and CA5A were identified as promising therapeutic targets. This present study reveals a significant causal relationship between mitochondria-associated proteins and SCZ, offering valuable insights into the disease’s pathogenicity and identifying potential therapeutic targets for drug development.
format Article
id doaj-art-423a069246224e2a8421dd0bbade71ea
institution Kabale University
issn 2754-6993
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Schizophrenia
spelling doaj-art-423a069246224e2a8421dd0bbade71ea2025-01-26T12:38:33ZengNature PortfolioSchizophrenia2754-69932025-01-011111910.1038/s41537-025-00559-4Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia riskWenxi Sun0Ping Sun1Jin Li2Qun Yang3Qing Tian4Shiting Yuan5Xueying Zhang6Peng Chen7Chuanwei Li8Xiaobin Zhang9Suzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversityQingdao Mental Health CenterSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversityNantong Mental Health CenterSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversitySuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversitySuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversitySuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversitySuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversitySuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow UniversityAbstract Numerous observational studies have highlighted associations between mitochondrial dysfunction and schizophrenia (SCZ), yet the causal relationship remains elusive. This study aims to elucidate the causal link between mitochondria-associated proteins and SCZ. We used summary data from a genome-wide association study (GWAS) of 66 mitochondria-associated proteins in 3,301 individuals from Europe, as well as a GWAS on the large, multi-ethnic ancestry of SCZ, involving 76,755 cases and 243,649 controls. We conducted bidirectional two-sample Mendelian randomization (MR) analyses, with inverse variance weighting (IVW) as the primary method. To account for multi-directionality and ensure robustness, we included MR-Egger, weighted median (WM), weighted mode, and simple mode methods as supplementary sensitivity analyses. Moreover, we explored the GWAS catalog and the Drug-Gene Interaction Database (DGIdb) to identify and evaluate potential therapeutic targets. MR analysis revealed significant genetically determined causal associations between ETHE1 (OR: 1.06), SOD (OR: 0.97), CALU3 (OR: 1.03), and C1QBP (OR: 1.05) and SCZ. According to the reverse MR analysis, a causal relationship was shown between SCZ and CA5A (OR: 1.09), DLD (OR: 1. 08), AIF1 (OR: 0.93), SerRS (OR: 0.93) and MULA of NFKB1 (OR: 0.77). After conducting the gene-drug analysis, HRG, F12, GPLD1, C1R, BCHE, CFH, PON1, and CA5A were identified as promising therapeutic targets. This present study reveals a significant causal relationship between mitochondria-associated proteins and SCZ, offering valuable insights into the disease’s pathogenicity and identifying potential therapeutic targets for drug development.https://doi.org/10.1038/s41537-025-00559-4
spellingShingle Wenxi Sun
Ping Sun
Jin Li
Qun Yang
Qing Tian
Shiting Yuan
Xueying Zhang
Peng Chen
Chuanwei Li
Xiaobin Zhang
Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
Schizophrenia
title Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
title_full Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
title_fullStr Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
title_full_unstemmed Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
title_short Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
title_sort exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
url https://doi.org/10.1038/s41537-025-00559-4
work_keys_str_mv AT wenxisun exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT pingsun exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT jinli exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT qunyang exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT qingtian exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT shitingyuan exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT xueyingzhang exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT pengchen exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT chuanweili exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk
AT xiaobinzhang exploringgeneticassociationsanddrugtargetsformitochondrialproteinsandschizophreniarisk